GBA Antikörper (AA 146-235)

Produktnummer ABIN561009

Produktdetails anti-GBA Antikörper

Target: GBA (Glucosidase, Beta, Acid (GBA))

Bindungsspezifität: AA 146-235

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser GBA Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (IF)

Verwendungszweck: Mouse monoclonal antibody raised against a partial recombinant GBA.

Sequenz: SYFSEEGIGY NIIRVPMASC DFSIRTYTYA DTPDDFQLHN FSLPEEDTKL KIPLIHRALQ LAQRPVSLLA SPWTSPTWLK TNGAVNGKGS

Kreuzreaktivität: Human

Produktmerkmale: Antibody Reactive Against Recombinant Protein.

Immunogen: GBA (NP_000148, 146 a.a. ~ 235 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.

Klon: 2E2

Isotyp: IgG2a

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Buffer: In 1x PBS, pH 7.4

Handhabung: Aliquot to avoid repeated freezing and thawing.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.

Referenzen für anti-GBA Antikörper (ABIN561009)

Murphy, Gysbers, Abbott, Tayebi, Kim, Sidransky, Cooper, Garner, Halliday: "Reduced glucocerebrosidase is associated with increased ?-synuclein in sporadic Parkinson's disease." in: Brain : a journal of neurology, Vol. 137, Issue Pt 3, pp. 834-48, (2014) (PubMed).

Bendikov-Bar, Rapaport, Larisch, Horowitz: "Parkin-mediated ubiquitination of mutant glucocerebrosidase leads to competition with its substrates PARIS and ARTS." in: Orphanet journal of rare diseases, Vol. 9, pp. 86, (2014) (PubMed).

Bendikov-Bar, Horowitz: "Gaucher disease paradigm: from ERAD to comorbidity." in: Human mutation, Vol. 33, Issue 10, pp. 1398-407, (2012) (PubMed).

Bendikov-Bar, Ron, Filocamo, Horowitz: "Characterization of the ERAD process of the L444P mutant glucocerebrosidase variant." in: Blood cells, molecules & diseases, Vol. 46, Issue 1, pp. 4-10, (2011) (PubMed).

Campeau, Rafei, Boivin, Sun, Grabowski, Galipeau: "Characterization of Gaucher disease bone marrow mesenchymal stromal cells reveals an altered inflammatory secretome." in: Blood, Vol. 114, Issue 15, pp. 3181-90, (2009) (PubMed).

Details zu GBA

Target: GBA (Glucosidase, Beta, Acid (GBA))

Andere Bezeichnung: GBA (GBA Produkte)

Synonyme: GBA1 antikoerper, GCB antikoerper, GLUC antikoerper, BETA-GLUCOSIDASE antikoerper, T12J13.8 antikoerper, T12J13_8 antikoerper, beta glucosidase 25 antikoerper, PSPTO3318 antikoerper, PSPTO4290 antikoerper, GC antikoerper, GCase antikoerper, betaGC antikoerper, glucosylceramidase beta antikoerper, beta glucosidase 25 antikoerper, beta-glucosidase antikoerper, Beta-glucosidase antikoerper, glucosidase, beta, acid antikoerper, glucosylceramidase antikoerper, bglX-2 antikoerper, GBA antikoerper, BGLU25 antikoerper, PSPTO_3318 antikoerper, bglX antikoerper, bglA4 antikoerper, Gba antikoerper, LOC100399524 antikoerper, bglA.2 antikoerper, bglX-2 antikoerper

Hintergrund: Full Gene Name: glucosidase, beta, acid (includes glucosylceramidase)
Synonyms: GBA1,GCB,GLUC

Gen-ID: 2629

NCBI Accession: NM_000157

Pathways: Cellular Glucan Metabolic Process